Keith Davies has made Chemical Design a world leader in molecular modeling LONDON—By now we’ve all seen the numbers and heard the gloomy forecasts. Science in the United Kingdom is suffering from a dearth of funding, incentives, and political clout. The lack of commitment to R&D on the part of both the private and public sectors in Britain has sparked an alarming emigration of scientists and high-tech entrepreneurs. But for every rule there is an exception, and Keith Davies is

A veterinary pathologist’s odyssey out of academia to become CEO of one of Europe’s hottest startups On the wall of Keith McCullagh’s office hangs a framed picture showing one of his company’s advertisements. “British biotechnology has come a long way since 1953,” says the legend above a picture of Francis Crick and James Watson, the discoverers of the double helix structure of DNA. For McCullagh, the snappy slogan has a double meaning. As it happens, Br

Alvey Provides Model for Collaboration BY JOHN STANSELL LONDON - The Alvey program in advanced microelectronics leaves a legacy of cooperative research that promises to outlast the completion of its last individual project later this year. Begun in June 1983, Alvey proved to be a model for government- university-industry collaboration, for joint efforts among competing companies, and for cooperative research throughout Europe. It has also received high marks for luring top scientists back to

LONDON—For the past 10 years Britain’s Medical Research Council (MRC) has fostered efforts to speed up the transfer of key inventions from academia to industry. Already hard at work on a new collaborative center to open next spring, MRC officials last month were pleased to learn that one of their most promising offspring is ready to grow up. Celitech, founded in 1980 largely with government money, has become the country’s leading inde pendent biotechnology company. The key

LONDON—Genentech's British patent on the blood clot-dissolving tissue plasminogen activator (TPA) has been revoked after a three-week trial that featured some of the world's leading biotechnologists. But High Court Justice John Whitford was not persuaded by the assertion of Nobel laureate Paul Berg of Stanford that Genentech had a monopoly on the skills needed to make TPA by recombinant DNA techniques when it filed its patent application in May 1983. Biochemist WJ. Brammar of the Universit

LONDON—One of Britain's leading retail electronics companies has thrown its weight behind a Thatcher government educational scheme to reverse inner-city decay and increase scientific and technical training in high schools. The plan, which establishes City Technology Colleges (CTC), has generated considerable controversy since its announcement at the Tory party conference last October. The government has admitted that it has not discussed the matter formally with teachers, administrators or

LONDON—Last month's sinking of the English Channel ferry the Herald of Free Enterprise has focused attention on a group of scientists and engineers whose unique expertise has been neglected in the rash of recent privatizations in Britain. Companies operating similar "roll-on, roll-off" (or Ro-Ro) ferries have not responded to efforts by the managers of the now privately owned company British Maritime Technology (BMT) to point out the design weaknesses of such craft. One consequence is that

LONDON—A novel international data base compiled on floppy disks may soon help American scientists disseminate their ideas for commercial applications of their work. This new venture in worldwide technology transfer is called Techstart International Inc. The New York company was founded by two entrepreneurs, Peter Ruof, formerly of the World Bank, and Paris del L'Etraz, a computer systems analyst with the Union Bank of Switzerland. The company plans to develop a network of national boards t

LONDON—Britain needs to spend $1.5 billion on information technology research and applications to extend the results of the Alvey program now underway, according to a new report from a committee of government, academic and university administrators. The so-called IT 86 committee, formed early last year, has recommended $800 million in further research and $700 million for applications programs over an unspecified five-year period. Of the total for research, $75 million would be allocated a